Qiagen ( (QGEN) ) just unveiled an update.
QIAGEN N.V. has announced the filing of its Form 20-F Annual Report for the fiscal year ending December 31, 2024, with the United States Securities and Exchange Commission (SEC). This filing is a regulatory requirement and provides stakeholders with detailed information about the company’s financial performance and operations, which is now accessible on QIAGEN’s website.
More about Qiagen
QIAGEN N.V. operates in the biotechnology industry, focusing on providing sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company is known for its products and services that enable customers to gain valuable insights from biological samples.
YTD Price Performance: -10.50%
Average Trading Volume: 1,193,839
Technical Sentiment Signal: Strong Buy
Current Market Cap: $8.67B
For an in-depth examination of QGEN stock, go to TipRanks’ Stock Analysis page.